Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 246

Peripheral Neural Plasticity in Cochlear Implant Users Across the Lifespan

Model-based analysis of ECAPs in CochlearImplant users showed stronger auditory nerve responses and plasticity in younger recipients, highlighting the value of early implantation.

Question Can neural responses measured in cochlear implant users be standardized to monitor auditory nerve health and plasticity over time?

Findings In this cohort study analyzing more than 169 000 recordings from more than 10 000 cochlear implants in 7,416 patients, auditory nerve activity varied by cochlear location and age at implantation. Children implanted at younger ages showed stronger responses and clear evidence of plasticity, particularly in the first 5 years after activation; these changes were not observed in older users.

Meaning Model-based analysis of neural recordings provide a scalable method for tracking auditory nerve health across the lifespan and highlight the importance of early implantation for long-term outcomes.

Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung Cancer

Open-source AI models for LungCancer EGFR mutation prediction showed high accuracy overall but reduced performance in Asian patients and pleural samples, indicating the need for broader validation.

Importance Artificial intelligence (AI) models are emerging as rapid, low-cost tools for predicting targetable genomic alterations directly from routine pathology slides. Although these approaches could accelerate treatment decisions in lung cancer, little is known about whether their performance is consistent across diverse patient populations and tissue contexts.

Objective To evaluate the performance and generalizability of 2 open-source AI pathology models for predicting EGFR mutation status in lung adenocarcinoma (LUAD) across independent cohorts and ancestral subgroups.

Design, Setting, and Participants This cohort study included patients with LUAD from 2 cohorts: Dana-Farber Cancer Institute (DFCI) from June 2013 to November 2023, and a European-based trial (TNM-I) from August 2016 to February 2022. All patients had paired next-generation sequencing data and hematoxylin-eosin–stained whole-slide images. In the DFCI cohort, genetic ancestry was inferred using germline genotype data. Data analyses were performed from July 2025 to September 2025.

Researchers uncover MraZ ‘donut’ deformation that triggers bacterial cell division

A research team led by UAB researcher David Reverter has discovered the molecular mechanism that describes in detail the process regulating cell division in bacteria, based on the binding of the MraZ protein to the dcw gene cluster. The research has been published in Nature Communications.

Cell division is a central process in all living organisms and requires the coordinated action of many proteins and other regulatory elements. In most bacteria, this process is encoded in a gene cluster called the dcw operon, which groups all the genes that produce the proteins necessary to carry out cell division and bacterial wall formation.

These sets of genes are activated by proteins that act as transcription factors: they bind to the promoter region of the gene, the DNA sequence that indicates the point to start transcription, just before the first codon (the basic unit of gene information) that codes for the beginning of the protein sequence. One of these transcription factors is MraZ, the first gene of the dcw operon in all bacteria. When activated, the necessary proteins (encoded within the genes of the operon) are produced so that the bacteria can divide. It is, therefore, the transcription factor that controls the activity of the operon responsible for cell division in most bacteria.

SREBP-1 upregulates SOAT1 to promote tumor growth by preventing lipotoxicity

Zhong et al. demonstrate that SREBP-1 and SOAT1 are co-upregulated in GBM and NSCLC, coupling cholesterol acquisition and storage. They reveal that SREBP-1 transcriptionally activates SOAT1, enabling cancer cells to sustain cholesterol homeostasis, and that targeting SOAT1 disrupts this balance, leading to ROS accumulation, mitochondrial dysfunction, and tumor cell death.

A drug to cure jet lag?

Adapting to eastward travel, such as west-to-east transmeridian flights, or to night-shift work requires advancing the internal clock, a process that normally takes longer and is physiologically harder than delaying it.

Existing methods, such as light therapy or melatonin, are heavily constrained by timing and often yield inconsistent results.

Mic-628’s consistent phase-advance effect, regardless of when it is administered, represents a new pharmacological strategy for resetting the circadian clock.

The researchers discovered that Mic-628 selectively induces the mammalian clock gene Per1.

Mic-628 works by binding to the repressor protein CRY1, promoting the formation of a CLOCK–BMAL1–CRY1–Mic-628 complex that activates Per1 transcription through a “dual E-box” DNA element.

As a result, both the central clock in the brain’s suprachiasmatic nucleus (SCN) and peripheral clocks in tissues such as the lungs were advanced—in tandem and independent of dosing time.

In a simulated jet lag mouse model (6-hour light-dark phase advance), a single oral dose of Mic-628 shortened re-entrainment time from seven days to four.

Continue reading “A drug to cure jet lag?” | >

Studies show 11 genetic variants affect gut microbiome

In two new studies on 28,000 individuals, researchers are able to show that genetic variants in 11 regions of the human genome have a clear influence on which bacteria are in the gut and what they do there. Only two genetic regions were previously known. Some of the new genetic variants can be linked to an increased risk of gluten intolerance, hemorrhoids and cardiovascular diseases.

The studies are published in the journal Nature Genetics.

The community of bacteria living in our gut, or gut microbiome, has become a hot research area in recent years because of its great significance for health and disease. However, the extent to which our genes determine which bacteria are present in the intestines has been unclear. Until now, it has only been possible to link a few genetic variants to the composition of the gut microbiome with certainty.

Brain mechanism behind ‘flashes of intuition’

Despite decades of research, the mechanisms behind fast flashes of insight that change how a person perceives their world, termed “one-shot learning,” have remained unknown. A mysterious type of one-shot learning is perceptual learning, in which seeing something once dramatically alters our ability to recognize it again.

Now a new study, the researchers address the moments when we first recognize a blurry object, a primal ability that enabled our ancestors to avoid threats.

Published in Nature Communications, the new work pinpoints for the first time the brain region called the high-level visual cortex (HLVC) as the place where “priors” — images seen in the past and stored — are accessed to enable one-shot perceptual learning.

“Our work revealed, not just where priors are stored, but also the brain computations involved,” said co-senior study author.

Importantly, past studies had shown that patients with schizophrenia and Parkinson’s disease have abnormal one-shot learning, such that previously stored priors overwhelm what a person is presently looking at to generate hallucinations.

“This study yielded a directly testable theory on how priors act up during hallucinations, and we are now investigating the related brain mechanisms in patients with neurological disorders to reveal what goes wrong,” added the author.

The research team is also looking into likely connections between the brain mechanisms behind visual perception and the better-known type of “aha moment” when we comprehend a new idea. ScienceMission sciencenewshighlights.

Continue reading “Brain mechanism behind ‘flashes of intuition’” | >
/* */